Search results for " Melanoma"

showing 10 items of 184 documents

Oncogenic BRAF protein as a molecular target of HDAC inhibitors in melanoma cells

2021

Settore BIO/10 - BiochimicaHDAC inhibitors melanoma BRAF
researchProduct

Parthenolide induces caspase-independent cell death in osteosarcoma, melanoma and breast cancer cells through the induction of oxidative stress.

2012

Parthenolide, a sesquiterpene lactone found in European feverfew, is used in traditional medicine for its anti-inflammatory activity. In addition, parthenolide has been considered as a novel and effective anti-tumor agent because it induces cytotoxic effects in several tumor cell lines. Our studies demonstrated that parthenolide exerted strong cytotoxic effects in osteosarcoma MG63 and melanoma SK-Mel28 cells in culture. Staining with Hoechst 33342 revealed in most cells after brief periods of treatments (3-5h) chromatin condensation and fragmentation, while only few cells were PI-positive. Prolonging the treatment (5-14h) PI-positive cells strongly augmented, denouncing the increase of nec…

Settore BIO/10 - BiochimicaParthenolide osteosarcoma melanoma oxidative stress.
researchProduct

Melanoma cells release extracellular vesicles which contain RNA-binding proteins able to bind the mRNA encoding histone H1°

2015

Extracellular vesicles (EVs) are produced by most prokaryotic and eukaryotic cells; tumour cells, however, release much higher amounts of EVs, which contain cancer-specific proteins and RNAs. Molecules carried by EVs are captured by surrounding cells, which then undergo profound phenotypic modifications. G26/24 oligodendroglioma cells release, for example, EVs containing FasL and TRAIL, which induce apoptosis in rat cortical neurons and astrocytes in culture. By metabolic labelling of cells, EV-mediated horizontal transfer of radioactive proteins was clearly demonstrated. Among the proteins present in EVs produced by oligodendroglioma cells, extracellular matrix remodelling proteases, and t…

Settore BIO/10 - BiochimicaSettore BIO/06 - Anatomia Comparata E CitologiaExtracellular vesicles (EVs) G26/24 oligodendroglioma cells xtracellular matrix remodelling proteases A375 melanoma cells H1° histone RNA-protein complexes myelin expression factor-2 (MYEF2)
researchProduct

RNA as a carrier of epigenetic information

2017

Both prokaryotic and eukaryotic cells release into the extracellular matrix membrane-bound structures of different sizes, origin and composition, collectively called extracellular vesicles (EVs) [1]. Tumor cells, in particular, use EVs to transfer both nucleic acids and proteins to the surrounding normal cells, thus inducing in them transformed behaviours or killing them. G26/24 oligodendroglioma cells, for example, transfer by EVs pro-apoptotic proteins, such as TRAIL and Fas-Ligand [2], extracellular matrix remodelling proteases (such as ADAMTS) [3], and even the H1.0 histone protein [4]. Another tumour cell line, with a different tissue origin (A375 melanoma cells) releases into the medi…

Settore BIO/10 - BiochimicaSettore BIO/06 - Anatomia Comparata E Citologiaextracellular vesicles (EVs) G26/24 oligodendroglioma cells extracellular matrix remodelling proteases H1.0 histone protein H1.0 mRNA A375 melanoma cells myelin expression factor-2 (MYEF2)
researchProduct

Porphyrin tributyltin(IV) complexes for a novel approach in the tratment of human melanoma

2012

Melanoma is the most deadly form of skin cancer, largely refractory to existing therapies. The study of porphyrin derivatives as potential anti-tumor drugs has been an interesting field of investigation in the last years. Recently, a photo-independent cytotoxic effect of (Bu3Sn)4TPPS in the blocking melanoma cell proliferation an inducing a morphology cell change was investigated.[1] Amphiphilic CD (ACyD) provides more water soluble and adaptable nanovectors through modulation of the balance between hydrophobic and hydrophilic chains at both CD sides. ACyD can be conveniently tailored by covalently appending fluorescent label or receptor-targeting glycosyl- groups and can encapsulate conven…

Settore CHIM/03 - Chimica Generale E Inorganicameso-Tetra(4-sulfonatophenyl)porphine anphiphylic cyclodextrins melanoma
researchProduct

(Bu3Sn)4TPPS and (Bu2Sn)2TPPS significantly inhibit the growth, migrationand tumorigenicity of human malignant melanoma cells

2018

Melanoma is one of the most aggressive and treatment-resistant human cancers, it is responsible worldwide for the 80% of skin cancer related deaths which is largely due to its propensity to metastasize to other organs. The growing understanding of the pathways involved in melanoma progression and development has led to the identification of some interesting new molecules, however, the treatment options for metastatic melanoma remain limited. Indeed, the key step in metastasis development is the tumour cell invasion of the nearby host tissue and the journey powerfully depends on the detachment of single tumour cells from the primary tumour. Therefore, the ability to block the migratory and i…

Settore CHIM/03 - Chimica Generale E Inorganicaorganotin(IV) melanoma cancer porphine
researchProduct

Distribution, function and predictive value of tumor-infiltrating γδ T lymphocytes

2013

Although γδ T cells are known to exert both tumor-preventing and tumor-promoting activity, there is still little information on the functional characteristics and clinical significance of γδ T cells isolated from the tumor site. In a recent study, we have investigated the distribution of different γδ T-cell populations in melanoma and their impact on disease outcome.

Settore MED/04 - Patologia GeneraleTumor-infiltrating lymphocytesDisease outcomebusiness.industryMelanomaImmunologymedicine.diseasePredictive valueTumor siteγδ T cellscytokinesOncologytumor-infiltrating lymphocytesγδ T cells cytokines cytotoxicity melanoma tumor-infiltrating lymphocytesImmunologymedicinemelanomaImmunology and AllergycytotoxicityClinical significanceCytotoxicitybusinessAuthor's ViewOncoimmunology
researchProduct

Studio dell'infiltrato linfocitario peritumorale e dei linfociti circolanti in pazienti affetti da melanoma cutaneo

2014

I linfociti T γδ sono un gruppo di effettori “natural killer” del sistema immunitario innato che hanno rappresentato un interessante oggetto di studio nel corso degli ultimi anni. Il Dipartimento di Discipline Chirurgiche, Oncologiche ed Odontostomatologiche del Policlinico Universitario di Palermo, da anni attivo nei confronti della ricerca scientifica, ha recentemente condotto uno studio mirato alla conoscenza del potenziale effetto immunoterapeutico di questa popolazione linfocitaria verso i melanomi in stadio avanzato. Sulla base della classificazione della American Joint Committee on Cancer (AJCC) i pazienti affetti da melanoma maligno in stadio IV con neoplasia metastatica hanno una p…

Settore MED/19 - Chirurgia PlasticaLinfociti T γδ Linfociti natural killer melanoma cutaneo trattamento del melanoma metastatico
researchProduct

Melanoma nei BRCA mutation carriers

2016

Settore MED/19 - Chirurgia PlasticaMELANOMA FAMILIAL MELANOMA brca MUTATION
researchProduct

Matrix metalloproteinases 2 and 9 in lentigo maligna melanoma

2009

Settore MED/35 - Malattie Cutanee E VenereeMatrix metalloproteinases lentigo maligna melanoma
researchProduct